We are live on
!
Find out more
FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$237M
1-Year Est. Return
107.53%
This Fund
S&P 500
This Quarter
Est. Return
+13.36%
1 Year Est. Return
+107.53%
3 Year Est. Return
+149.4%
5 Year Est. Return
+13.8%
10 Year Est. Return
–
AUM
$371M
AUM Growth
+$13.9M
(+3.9%)
Cap. Flow
-$17.6M
Cap. Flow
% of AUM
-4.73%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
4
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quantum-Si Incorporated
QSI
|
+$10.3M |
| 2 |
Nurix Therapeutics
NRIX
|
+$4.01M |
| 3 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
+$1.7M |
| 4 |
Aclaris Therapeutics
ACRS
|
+$1.28M |
| 5 |
Pharvaris
PHVS
|
+$280K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BCM
AG
FL
PVM
MFA
TCM
WW
CB
Foresite Capital Management IV's Q2 2022 Portfolio in Review
As of Q2 2022, Foresite Capital Management IV held 9 positions worth $371M, up 3.9% from $357M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Foresite Capital Management IV withdrew a net $17.6M in Q2 2022, closing 1 position and reducing 4 holdings. Its most notable exit was Cue Health Inc. Common Stock, an estimated $1.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management IV's biggest Q2 2022 reduction was Quantum-Si Incorporated, cutting an estimated $10.3M.
- Foresite Capital Management IV fully exited Cue Health Inc. Common Stock in Q2 2022, selling an estimated $1.7M.
- Foresite Capital Management IV's ten largest holdings make up 100% of its $371M portfolio in Q2 2022.
- Foresite Capital Management IV opened 0 new positions and closed 1 in Q2 2022.
- Foresite Capital Management IV's portfolio value rose 3.9% quarter-over-quarter to $371M.
Based on Foresite Capital Management IV's 13F filing for Q2 2022, filed 12 Aug 2022.